Patent details

Basic Information

Publication number:

EP3206711

PCT Application Number:

US2015055390

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157849076

PCT Publication Number:

WO2016061142

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

French Title of Invention:

MOLÉCULES D'ANTICORPS DE PD-L1 ET LEURS UTILISATIONS

German Title of Invention:

ANTIKÖRPERMOLEKÜLE GEGEN PD-L1 UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

13/10/2015

Grant date:

31/05/2023

EP Publication Date:

23/08/2017

PCT Publication Date:

21/04/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/05/2023

EP B1 Publication Date:

31/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/10/2023

Expiration date:

13/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/05/2023

 

 

Name:

Dana-Farber Cancer Institute, Inc.

Address:

450 Brookline Avenue, Boston, MA 02215-5450, United States (US)

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

President and Fellows of Harvard College

Address:

17 Quincy Street, Cambridge, MA 02138, United States (US)

Inventor

1

Name:

SHARPE, Arlene, Helen

Address:

United States (US)

2

Name:

FREEMAN, Gordon, James

Address:

United States (US)

3

Name:

CHANG, Hwai, Wen

Address:

United States (US)

4

Name:

FREY, Gerhard, Johann

Address:

United States (US)

5

Name:

MATARAZA, Jennifer, Marie

Address:

United States (US)

6

Name:

DRANOFF, Glenn

Address:

United States (US)

Priority

1

Priority Number:

201462063852 P

Priority Date:

14/10/2014

Priority Country:

United States (US)

2

Priority Number:

201462094847 P

Priority Date:

19/12/2014

Priority Country:

United States (US)

3

Priority Number:

201562198545 P

Priority Date:

29/07/2015

Priority Country:

United States (US)

4

Priority Number:

201562213076 P

Priority Date:

01/09/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/28; C07K 16/46; C07K 16/30; A61P 31/00; A61P 35/00; A61P 35/02; A61P 37/02;

Publication

European Patent Bulletin

Issue number:

202322

Publication date:

31/05/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages